Fear and the lost opportunity

On 7 February 2020, if my memory serves me right, I bought 50,000 shares of Medtecs International (546.SI) at just over 10 cents each. I remember placing the order only seconds before the Singapore market closed at 5 p.m.

What happened next is one of those stories I tell myself I have learned from. I am still not entirely sure I have.

The setup

Medtecs is a manufacturer of medical protective equipment: masks, gowns and gloves. In early February 2020, Covid-19 was still being referred to cautiously as a “novel coronavirus”, and Singapore was operating at DORSCON Yellow. PPE was not yet the household term it would become.

I bought the stock on instinct, on the thesis that masks and protective equipment were going to be in demand. The timing felt right. The price felt low.

Later that evening, the Ministry of Health announced that Singapore’s risk assessment had been raised from DORSCON Yellow to DORSCON Orange.

Ministry of Health Singapore news page headed “Risk assessment raised to DORSCON Orange”, dated 7th Feb 2020. Paragraph 3 is outlined in red: as there are now a few local cases without any links to previous cases or travel history to China, the risk assessment has been stepped up from DORSCON Yellow to DORSCON Orange.
MOH announcement raising DORSCON to Orange, 7 February 2020.

I had bought a PPE stock on the same day Singapore officially escalated its pandemic response. By accident. I felt like a genius.

The unravelling

The stock moved in the right direction over the following days. Medtecs was one of the few companies positioned to meet the sudden surge in demand for masks and PPE. The thesis was playing out.

Then the Deputy Executive Chairman disclosed that he had disposed of a significant portion of his shares.

That was enough for me. An insider was selling, the person who knows the company best, and it felt like a signal I could not ignore. The stock price started to soften, and my conviction evaporated almost immediately.

I sold everything on 20 February 2020.

CDP securities transaction statement for Medtecs Intl: a purchase of 50,000 shares through DBS Vickers Securities (S) Pte Ltd in an entry dated 11/02/2020, and a sale of 50,000 shares in an entry dated 20/02/2020, with no remaining balance.
CDP transaction record showing the Medtecs purchase and sale entries in February 2020.

Fifty thousand shares bought, fifty thousand shares sold. Total profit: approximately ten dollars, after fees.

What happened next

A few months later, Medtecs hit a high of around SGD 2.00 per share.

The stock I had bought at 10 cents went to SGD 2, a 20x rise. Had I held all 50,000 shares to that peak, the gain would have been close to SGD 100,000.

At the time of writing this post in February 2021, the stock is sitting at around SGD 1.09, still roughly a 10x return from my entry price.

I sold for ten dollars.

The lesson, honestly

The easy version of this story is: don’t panic sell, hold your winners, ignore short-term noise. That is all true.

But the more honest version is about what actually happened in the moment. I saw an insider selling and did not ask why, or whether it mattered to my thesis. I just felt fear, the specific fear of watching a gain disappear, and I acted on it immediately.

The fundamental case for Medtecs had not changed. A global pandemic was accelerating. PPE demand was nowhere near its peak. None of that had changed because one executive decided to take some money off the table.

I had a thesis. I abandoned it because someone else’s action frightened me.

The lesson I took: hold any stock based on its fundamentals, not on what other people are doing with theirs. Don’t let fear make decisions that your research should be making.

I have not always applied this lesson since. But I have not forgotten it either.


This is not financial advice. It is a record of one trade, one mistake, and what I took from it. Your situation is different from mine. Please make your own decisions.